Smart Money Is Betting Big In VKTX Options
Smart Money Is Betting Big In VKTX Options
Deep-pocketed investors have adopted a bearish approach towards Viking Therapeutics (NASDAQ:VKTX), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in VKTX usually suggests something big is about to happen.
深口袋的投資者對Viking Therapeutics（NASDAQ:VKTX）採取了看淡的態度，這是市場參與者不應忽視的事情。我們在Benzinga的公共期權記錄跟蹤中發現了這個重要的動向。這些投資者的身份尚不清楚，但VKTX的這樣巨大的變動通常意味着即將發生一些重要的事情。
We gleaned this information from our observations today when Benzinga's options scanner highlighted 9 extraordinary options activities for Viking Therapeutics. This level of activity is out of the ordinary.
我們從今天的觀察到的信息中獲知維京治療公司的9項非同尋常期權交易，這種活動水平超出尋常。
The general mood among these heavyweight investors is divided, with 0% leaning bullish and 77% bearish. Among these notable options, 4 are puts, totaling $180,170, and 5 are calls, amounting to $377,168.
這些重量級投資者的總體情緒分歧，0%看漲，77%看跌。在這些顯著的期權中，有4個看跌，總額爲180,170美元，有5個看漲，總額爲377,168美元。
What's The Price Target?
目標價是多少？
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $20.0 and $75.0 for Viking Therapeutics, spanning the last three months.
通過評估成交量和未平倉合約量，顯然主要的市場推動者關注維京治療公司的20.0到75.0美元的價格區間，涵蓋了最近三個月。
Volume & Open Interest Development
成交量和持倉量的評估是期權交易中的一個關鍵步驟。這些指標揭示了阿里巴巴集團（Alibaba Gr Hldgs）特定執行價格期權的流動性和投資者興趣。下面的數據可視化了在過去30天內，阿里巴巴集團（Alibaba Gr Hldgs）在執行價格在74.0美元到120.0美元區間內的看漲看跌期權中，成交量和持倉量的波動情況。
In terms of liquidity and interest, the mean open interest for Viking Therapeutics options trades today is 486.33 with a total volume of 113.00.
就流動性和興趣而言，維京治療公司期權今日的平均未平倉合約量爲486.33，總成交量爲113.00。
In the following chart, we are able to follow the development of volume and open interest of call and put options for Viking Therapeutics's big money trades within a strike price range of $20.0 to $75.0 over the last 30 days.
在下面的圖表中，我們能夠跟蹤維京治療公司大手交易中期權看漲和看跌未平倉合約和成交量在20.0到75.0美元行權價格區間內的發展，時間跨度爲過去30天。
Viking Therapeutics Call and Put Volume: 30-Day Overview
維京治療公司看漲和看跌期權的成交量：30天概述
Significant Options Trades Detected:
檢測到重大期權交易：
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|---|---|---|
| VKTX | CALL | TRADE | BEARISH | 01/16/26 | $37.0 | $33.3 | $34.73 | $20.00 | $173.6K | 299 | 24 |
| VKTX | CALL | TRADE | NEUTRAL | 01/16/26 | $33.8 | $29.1 | $31.48 | $25.00 | $94.4K | 54 | 30 |
| VKTX | PUT | TRADE | BEARISH | 09/20/24 | $9.1 | $8.6 | $8.91 | $50.00 | $62.3K | 954 | 2 |
| VKTX | PUT | SWEEP | BEARISH | 11/15/24 | $6.0 | $5.9 | $6.0 | $40.00 | $53.4K | 915 | 40 |
| VKTX | CALL | TRADE | BEARISH | 01/16/26 | $37.0 | $35.5 | $35.75 | $20.00 | $39.3K | 299 | 2 |
| 標的 | 看跌/看漲 | 交易類型 | 情緒 | 到期日 | 賣盤 | 買盤 | 價格 | 執行價格 | 總交易價格 | 未平倉合約數量 | 成交量 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| VKTX | 看漲 | 交易 | 看淡 | 01/16/26 | $37.0 | $33.3 | 34.73美元 | $20.00 | 173.6K | 299 | 24 |
| VKTX | 看漲 | 交易 | 中立 | 01/16/26 | $33.8應該是指目標價$33.8。 | $29.1 | $31.48 | $25.00 | $94.4K | 54 | 30 |
| VKTX | 看跌 | 交易 | 看淡 | 09/20/24 | $9.1 | $8.6美元 | $8.91 | $50.00 | $62.3K | 954 | 2 |
| VKTX | 看跌 | SWEEP | 看淡 | 11/15/24 | $6.0 | $5.9 | $6.0 | $40.00 | $53.4K | 915 | 40 |
| VKTX | 看漲 | 交易 | 看淡 | 01/16/26 | $37.0 | $35.5 | 35.75美元 | $20.00 | $39.3K | 299 | 2 |
About Viking Therapeutics
關於Viking Therapeutics
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.
Viking Therapeutics Inc是一家衛生服務提供商，專門從事代謝和內分泌障礙領域的生物製藥開發。該公司的臨床項目流水線包括VK2809、VK5211、VK0214產品。VK2809和VK0214是口服、組織和受體亞型選擇性的甲狀腺激素受體β激動劑。VK5211是一種口服、非類固醇選擇性雄激素受體調節劑。
Having examined the options trading patterns of Viking Therapeutics, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance
經過檢查Viking Therapeutics的期權交易模式，我們現在將我們的注意力直接轉向公司。這一轉變使我們可以深入研究其當前的市場地位和表現。
Viking Therapeutics's Current Market Status
維京治療公司的當前市場狀態
- With a trading volume of 1,554,339, the price of VKTX is down by -0.42%, reaching $49.63.
- Current RSI values indicate that the stock is is currently neutral between overbought and oversold.
- Next earnings report is scheduled for 6 days from now.
- 維京治療公司的交易量爲1,554,339，價格下跌-0.42%，達到49.63美元。
- 目前的RSI值表明該股票目前處於超買和超賣之間的中立狀態。
- 下一個收益報告將在6天后發佈。
Expert Opinions on Viking Therapeutics
維京治療公司的專家意見
Over the past month, 2 industry analysts have shared their insights on this stock, proposing an average target price of $97.5.
在過去的一個月裏，有2位行業分析師分享了他們關於該公司的見解，提出了97.5美元的平均目標價格。
- In a cautious move, an analyst from Morgan Stanley downgraded its rating to Overweight, setting a price target of $105.
- An analyst from HC Wainwright & Co. downgraded its action to Buy with a price target of $90.
- 爲了謹慎起見，摩根士丹利的一名分析師將其評級降級爲看漲，設定目標價爲105美元。
- Wainwright公司的一名分析師將其行動降級爲買入，並設定了90美元的目標價格。
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Viking Therapeutics with Benzinga Pro for real-time alerts.
交易期權涉及更大的風險，但也提供了更高的利潤潛力。精明的交易者通過持續教育、戰略性的交易調整、利用各種因子和保持市場動態來減輕這些風險。使用Benzinga Pro即可了解Viking Therapeutics的最新期權交易情況，並獲取實時警報。